目的评价国产普卢利沙星治疗轻、中度急性细菌感染的临床疗效与安全性。
Objective To evaluate the clinical efficacy and safety of prulifloxacin for the treatment of slight and moderate acute bacterial infections.
他说，在受试的感染人群中，服用普卢利沙星的人中有71%在48小时内痊愈了，而安慰剂组仅有33%。
In those who could be tested for infection, 71 percent were well within 48 hours after getting prulifloxacin, compared to 33 percent of those given a placebo pill, he said.
目的：改进普卢利沙星的生产工艺。
OBJECTIVE: To improve the production technology of prulifloxacin.
产品名称：普利沙星;普卢利沙星;6-氟-1-甲基-7-[4-(5-甲基-2-氧代-1,3-二氧杂环戊烯-4-基)-甲基-1-哌啶基]-4-氧代-4H-[1,3]硫氮杂环丁烷并[3,2-a]喹啉-3-羧酸 英文名：Prulifloxacin 别名：(+/-)-7-{4-[(Z)-2,3-Dihydroxy-2-butenyl]-1-piperazinyl}-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid cyclic carbonate; 6-Fluoro-1-methyl-7-(4-(5-methyl-2-oxo-1,3-dioxelen-4-yl)methyl-1-piperazinyl)-4-oxo-4H-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic acid 分子式：C21H20FN3O6S 分子量：461.46 CAS登录号：123447-62-1 普利沙星分子结构式：
应用推荐